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BACKGROUND It has been established the effectiveness of paclitaxel-
coated balloon (PCB) catheter in patients with in-stent restenosis.
However, the transient slow coronary ﬂow (TSCF), which may cause
the myocardial damage, was sometimes observed just after the dila-
tion of PCB in the clinical trials. The purpose of this study was to
investigate the incidence, predictors and outcomes of TSCF just after
PCB angioplasty.
METHODS We enrolled 21 patients who underwent the elective PCB
angioplasty for in-stent restenosis. We assessed the troponin-I level
12-18 hours after PCB angioplasty. TSCF was deﬁned as the decrement
of TIMI grade appearing just after PCB angioplasty.
RESULTS Final TIMI grade 3 was obtained in all patients. There was a
trend that TIMI frame count was greater just after PCB inﬂation
(39.419.2 vs. 35.418.3, p¼0.1). The TSCF just after PCB angioplasty
was observed in 8 (38%) patients. Most patients of TSCF group
showed prior myocardial infarction (87.5% vs. 15.4%, p¼0.002). There
was no signiﬁcant difference in troponin-I level between two groups
[TSCF (+) vs. (-): 0.380.86 vs. 0.501.42 ng/mL, p¼0.85].
CONCLUSION TSCF just after PCB angioplasty was not a rare phe-
nomenon, associated with prior myocardial infarction. This phe-
nomenon was not related to troponin-I level elevation.
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BACKGROUND Diffuse long lesion of coronary artery remains difﬁcult
to treat in the era of drug-eluting stent (DES). The purpose of this
study is to compare lesional outcomes of long and short stent im-
plantation in one patient with two vessel disease.
METHODS From May 2005 to August 2011, a total of 154 patients with
308 lesions who had two vessel disease and performed percutaneous
coronary intervention (PCI) with long and short DES for the two le-
sions was enrolled. Long segment stent was deﬁned as implantation
of DES over 50 mm and short less than 50mm. Same kinds of DES were
used in one patient. Angiographic follow-up was done at 8 months
and clinical follow-up was done for 36 months. The study end-points
were angiographic late loss, the rate of in-stent restenosis (ISR)
deﬁned as  50% of a diameter stenosis and major adverse cardiac
events (MACE) including all-cause death, target lesion revasculariza-
tion (TLR), target vessel revascularization (TVR) and lesion related
myocardial infarction (MI).
RESULTS Stent length was 61.6  11.6 mm in long lesion and 25.4 
8.5 mm in short lesion. Follow-up angiography was performed in 50%
(77/154). In-stent restenosis was observed in 7.8% in long lesion and
3.9% in short lesion (p¼0.145). Late loss at 8 months was statistically
signiﬁcant (0.62  0.61 mm in long lesion vs. 0.380.66 mm in short
lesion, p¼0.024). Target lesion revascularization was observed in
5.8% in long lesion and 2.6% in short lesion (p¼0.156). Target vessel
revascularization was observed in 5.8% in long lesion and 3.2% in
short lesion (p¼0.274). Total MACE was observed 8.4% in long lesion
and 6.5% in short lesion (p¼0.516).
CONCLUSION There was higher late loss in long lesion than short
lesion. However, clinical outcomes between long and short lesion for
36 months were not different. Further longer term follow-up and
larger population study will be needed.
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Characteristics of Coronary Stent Fracture After Stents Implantation
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BACKGROUND Coronary stents were more widely used in treatment
of narrowed coronary artery. As a relatively rare complication, char-
acteristics of coronary stent fracture deserve to be made certain.The study was to investigate the clinical, angiographic and procedural
characteristics of coronary stent fracture.
METHODS From January 2006 to August 2014, 6579 patients received
stents implantation. The angiograms of all 2407 patients who under-
went repeat angiography were studied to identify the presence of
stent fracture. The clinical, angiographic, procedural, and structural
factors which might predispose to stent fracture were systematically
analyzed.
RESULTS 1) Stent fracture was identiﬁed in 6 patients. The median
time interval from stent implantation to detection of fracture at
repeat angiography was 398 days (range: 220w2516 days). 1 stent
fracture occurred in left anterior descending artery (LAD) in one pa-
tient presented with acute ST-elevation myocardial infarction
(STEMI). 6 stent fractures in 5 cases who presented with unstable
angina (UAP) or asymptomatic occurred in right coronary artery
(RCA). 2) 5 stent fractures occurred at tortuous segment of coronary
artery with minor angulation, but with apparent calciﬁcation. The
original lesions where fractured stents deployed were RCA chronic
total occlusion (CTO) or sub-CTO in 4 patients. 3) 5 patients have
overlapping stents, 3 patients underwent post dilatation with high-
pressure balloons. 4) Stents fracture occurred near the joint site of
overlapping stents in 5 cases. Complete transverse disarticulation
occurred in 4 patients. Acute stent thrombosis secondary to stent
fracture occurred in one patient, binary focal restenosis associated
with fracture was detected in 3 patients, and both of them underwent
repeat drug-eluting stenting.
CONCLUSION Predisposing clinical and procedural factors may be
associated with the characteristics of diseased vessel and use of long
stent, overlapping stents and post dilatation with high-pressure bal-
loons. Stent fracture more occurred at tortuous segment, near the
joint site of overlapping stents in RCA. Patients with stent fracture
may be asymptomatic, but restenosis and thrombosis may be the
principal adverse events in a few patients.
HIGH RISK PATIENTS: DIABETES, HEART FAILURE, RENAL
FAILURE, OTHERS (TCTAP A-065 TO TCTAP A-072)
TCTAP A-065
Which Biomarker Can Predict Higher Syntax Score?
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BACKGROUND Syntax Score is an anatomical score of Coronary
angiograghy to predict outcome of revascularization by Percutaneous
Coronary Angioplasty or Coronary Artery Bypass grafting Surgery.
There were no laboratorium biomarker data to predict Syntax Score.
METHODS Patient who underwent coronary angiography and severity
evaluated by Syntax Score and Clinical Syntax Score and blood
examiner to determine the neutrophyl - lymphocyte ratio, basophyl,
eosinophyl, monocyte, hemoglobin, hematocrit, liver function other
factors, hs - CRP, total cholesterol, LDL cholesterol, HDL cholesterol,
triglycerides, and of functions ureaum, creatinine , HbA1C and the
other biomarker.
RESULTS One hundred and ﬁve patients, 82 % male and 18%
female, 16 patients (15 %) without any symptom of ischemic, 4 pa-
tients (3.8 %) angina pectoris ccs I, 30 patients (29 %) angina pectoris
ccs II, 32 patients (30 %) angina pectoris ccs III, 21 patients (20 %)
angina pectoris ccs IV There were no correlation between higher
syntax score  34 Hypertension (25.5 vs 22.43, p¼0.227), diabetes
(25.25 vs 22.97, p¼0.38) dyslipidemia (23.77 vs 23.79 p¼0.997).
analysis linear regression only ureum has signiﬁcant correlation to
higher syntax score  34 (p ¼ 0.016 and 95% conﬁdence interval
0.05-0.55).
Predict higher Syntax Score  34 can be used by module ¼
RISK Syntax 34 [ -3.126967+ 0.9225703*HDL40 +
1.423749*Ureum23 + 0.8085509*Rasio + 0.2834972*HBA1C_6.5
+0.8379034*monosit9).
[ 35 ( HDL £ 40 mg / dL ) + 43 ( ureum ‡ 23 mg / dL ) +25 (Neutrphyl-
lymphocyte ratio ‡ 3.789474 ) +10 ( HBA1C‡ 6.5 % ) + 29 ( Monocyte
‡9 % )
Probability/Risk Syntax Score 34¼ Probablitas/Risk Syntax Score 34 :
¼ . 1 ___________________
1+e-(-3.126967 + 0.9225703*HDL40 +1.423749*Ureum23 + 0.8085509*Rasio +
0.2834972*HBA1C_6.5 + 0.8379034*monosit9)
CONCLUSION Biomarker Ureum, HDL Cholesterol, Ratio Neutrophyl -
Limphocyte level , HbA1c, and Monocyte will predict patient high risk
with Syntax score more than 34.
